In editorials, Ruediger Krech & Marie-Paule Kieny (622) discuss the ethical implications of testing treatments for Ebola virus disease. Oleg Chestnov et al. (623) explain why noncommunicable disease control is integral to development goals.
Jane Parry (626–627) reports on China’s moves to produce vaccines for the global market. Bruno Vellas (628–629) talks to Fiona Fleck about identifying frail elderly patients in order to improve their quality of life.
Austria, Estonia, Finland, Greece, Ireland, Portugal, Slovakia & Spain
Responding to instability
Christine Leopold et al. (630–640) examine the effects of economic recession on pharmaceutical pricing policies.
Albania, Latvia, Lithuania, Montenegro, Romania, the Russian Federation, The former Yugoslav Republic of Macedonia & Turkey
Detecting late effects
Mark A Bellis et al. (641–655) examine correlations between harmful behaviour and adverse childhood experiences.
Bangladesh, Ethiopia, Ghana, India, Pakistan, Uganda, the United Republic of Tanzania
A persistent killer
Ahmed Ehsanur Rahman et al. (664–671) examine a decade of child deaths from diarrhoea.
Mozambique
Bringing care to patients
Troy D Moon et al. (680–684) describe the use of a mobile clinic for antiretroviral therapy.
Brazil
Improving vector control
Rafael Maciel-de-Freitas & Denise Valle (685–689) explain lessons learnt in trying to control Aedes aegypti.
Malawi
Overcoming the lack of a neighbourhood map
Veronica Escamilla et al. (690–694) use satellite imagery to identify households.
Global
Changing definitions
Susan D Cochran et al. (672–679) discuss declassification of disease categories related to sexual orientation.
Ensuring adverse events are reported
Christine G Maure et al. (695–696) introduce the Global Vaccine Safety Initiative.